Partnerships are at the core of what we do. We’re proud to work with partners around the world to advance global health innovations locally and globally.
At IAVI, we join forces with public and private partners to accelerate the development of biomedical innovations in areas where there is no market incentive and to tailor products for the people who need them most.
We have alliances with more than 150 leading global and national organizations. Our diverse network of partners includes other product development partnerships, industry, academia, civil society organizations, government agencies, policymakers, and community members.
We work closely with our advocacy partners to ensure that the necessary resources and policies are in place to support the development of global health innovations.
We work hand in hand with local groups where the need is greatest to understand their needs, support local scientists, and build and advance pathways that enable affordability and access.
We believe in scientific collaboration, and that’s why we share resources with other innovators across the field to help the global health community as a whole succeed.
Highlighting global partnerships
MTBVAC
IAVI, the Spanish biopharmaceutical company Biofabri (a subsidiary of Zendal), the University of Zaragoza, the TB Vaccine Initiative, and other groups are working in partnership on product development of one of the most promising new TB vaccine candidates in the pipeline. MTBVAC is the only live‑attenuated Mycobacterium tuberculosis vaccine in clinical development.
Together, IAVI and Biofabri are advancing MTBVAC across age groups, with Biofabri leading clinical development for newborns and IAVI leading clinical development for adolescents and adults in Africa. IAVI also leads access planning for the partnership, supported by a global manufacturing footprint spanning Europe, India, and South America to promote equitable availability once licensed.
IAVI sponsors the IMAGINE Phase 2b trial, a large safety and efficacy study enrolling about 4,300 adolescents and adults with latent TB infection across South Africa, Kenya, and Tanzania, and including a cohort of 1,200 individuals who have never been exposed to M.tb (IGRA‑negative). Biofabri concurrently leads the MTBVACN3 Phase 3 trial evaluating MTBVAC in newborns in several TB‑endemic African countries.
Learn more about the IMAGINE trial
The HIV PNP Task Force
The HIV Peri- and Post-Natal (PNP) Task Force is a diverse, global, multi-stakeholder collaboration established by IAVI to accelerate the development of bnAbs as an innovative prevention strategy to protect infants from HIV acquisition. The Task Force brings together more than 100 experts representing 49 organizations across 19 countries and four World Health Organization regions. Its membership spans researchers, funders, advocates, community representatives, clinicians, regulatory authorities, global health institutions, and product developers ensuring a comprehensive and inclusive approach to advancing this emerging intervention. Organized across seven strategic pillars (enabling science, clinical development, community partnership, regulatory, policy, manufacturing and access, and advocacy) the partnership began convening in 2023. Through sustained collaboration, members worked collectively to develop and launch Accelerating bnAbs for peri-and post-natal HIV prophylaxis: An Action Plan in 2024 aimed at accelerating the clinical development, licensure, and equitable access to HIV bnAbs for PNP.
Beyond the launch of the action plan, the HIV PNP Task Force continues to function as a dynamic collaborative platform, fostering cross-sector alignment, sharing emerging evidence and programmatic updates, and advancing a shared commitment to delivering effective HIV prevention options for infants.
Learn more about the Task Force
Partner with us
IAVI partners with academic, industry, governmental, NGO, multilateral, and civil society partners to advance solutions for public health threats that disproportionately affect people living in poverty. We welcome inquiries about how we can work together.
Contact our business development and alliance management team at partner@iavi.org.
Reach out